 Reexamination blood lymphocyte transformation test diagnosis chronic beryllium disease cell response beryllium bronchoalveolar lavage lymphocyte transformation test LTT critical diagnostic test chronic beryllium disease CBD granulomatous diseases sensitivity reproducibility methods invasive peripheral blood LTT patients CBD beryllium-exposed control subjects Ninety-four percent CBD cases abnormal blood LTT results beryllium-exposed control subjects normal blood LTT results Split beryllium disease cases control subjects blood LTT reproducible separate laboratories LTT sensitive serum culture medium abnormal blood LTT CBD patients compatible lung pathology